ATE225352T1 - Pyrrolo(2,1-b)(1,3)benzothiazepine mit atypisch antipsychotischer wirkung - Google Patents

Pyrrolo(2,1-b)(1,3)benzothiazepine mit atypisch antipsychotischer wirkung

Info

Publication number
ATE225352T1
ATE225352T1 AT99936971T AT99936971T ATE225352T1 AT E225352 T1 ATE225352 T1 AT E225352T1 AT 99936971 T AT99936971 T AT 99936971T AT 99936971 T AT99936971 T AT 99936971T AT E225352 T1 ATE225352 T1 AT E225352T1
Authority
AT
Austria
Prior art keywords
benzothiazepines
pyrrolo
atypical antipsychotic
antipsychotic action
compounds
Prior art date
Application number
AT99936971T
Other languages
English (en)
Inventor
Giuseppe Campiani
Vito Nacci
Patrizia Minetti
Cesare Maria Assunta Di
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE225352T1 publication Critical patent/ATE225352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
AT99936971T 1998-07-28 1999-07-27 Pyrrolo(2,1-b)(1,3)benzothiazepine mit atypisch antipsychotischer wirkung ATE225352T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001748A IT1301965B1 (it) 1998-07-28 1998-07-28 Pirrolo (2,1-b)(1,3) benzotiazepine con attivita' antipsicoticaatipica.
PCT/IT1999/000240 WO2000006579A2 (en) 1998-07-28 1999-07-27 Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity

Publications (1)

Publication Number Publication Date
ATE225352T1 true ATE225352T1 (de) 2002-10-15

Family

ID=11380538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936971T ATE225352T1 (de) 1998-07-28 1999-07-27 Pyrrolo(2,1-b)(1,3)benzothiazepine mit atypisch antipsychotischer wirkung

Country Status (14)

Country Link
US (1) US6391870B2 (de)
EP (1) EP1100803B1 (de)
JP (1) JP4523160B2 (de)
KR (1) KR100642730B1 (de)
AT (1) ATE225352T1 (de)
AU (1) AU762021B2 (de)
CA (1) CA2338651C (de)
DE (1) DE69903321T2 (de)
DK (1) DK1100803T3 (de)
ES (1) ES2185384T3 (de)
HK (1) HK1036793A1 (de)
IT (1) IT1301965B1 (de)
PT (1) PT1100803E (de)
WO (1) WO2000006579A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317886B1 (it) 2000-08-01 2003-07-15 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di 9,10-diidro-pirrolo (2,1-b)(1,3)benzotiazepine 9-ammino sostituite.
IT1317884B1 (it) 2000-08-01 2003-07-15 Sigma Tau Ind Farmaceuti Pirrolo (2,1-b)(1,3)benzotiazepine e loro uso per la preparazione dimedicamenti ad attivita' antipsicotica classica.
ITRM20040178A1 (it) * 2004-04-07 2004-07-07 Sigma Tau Ind Farmaceuti Composti ad attivita' antipsicotica atipica.
ITRM20040222A1 (it) * 2004-05-07 2004-08-07 Sigma Tau Ind Farmaceuti Derivati dealchilati di pirrolo[2,1-b]benzotiazepine ad attivita' antipsicotica atipica.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines

Also Published As

Publication number Publication date
KR100642730B1 (ko) 2006-11-03
ITMI981748A0 (it) 1998-07-28
KR20010072090A (ko) 2001-07-31
PT1100803E (pt) 2003-02-28
AU762021B2 (en) 2003-06-19
CA2338651C (en) 2009-05-19
EP1100803A2 (de) 2001-05-23
DK1100803T3 (da) 2002-12-30
IT1301965B1 (it) 2000-07-20
CA2338651A1 (en) 2000-02-10
WO2000006579A2 (en) 2000-02-10
ES2185384T3 (es) 2003-04-16
JP2002521485A (ja) 2002-07-16
DE69903321T2 (de) 2003-06-18
ITMI981748A1 (it) 2000-01-28
US20020006921A1 (en) 2002-01-17
US6391870B2 (en) 2002-05-21
HK1036793A1 (en) 2002-01-18
WO2000006579A3 (en) 2000-05-04
AU5193399A (en) 2000-02-21
DE69903321D1 (de) 2002-11-07
EP1100803B1 (de) 2002-10-02
JP4523160B2 (ja) 2010-08-11

Similar Documents

Publication Publication Date Title
DE69724811D1 (de) Pentafluorobenzensulfonamide und analoge
WO1997030677A3 (en) Pentafluorobenzenesulfonamides and analogs
ATE309237T1 (de) Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
FI943542A (fi) Trisyklisiä bentsatsepiineja, jotka ovat vasopressiiniantagonisteja
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
ATE280756T1 (de) Substituierte benzolverbindungen als antiproliferative mittel
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
IL143105A0 (en) Fused polycyclic heterocyclic compounds and pharmaceutical compositions containing the same
BR9709326A (pt) Miméticos g-csfnão peptídios
EA200101234A1 (ru) Новые производные аминотиазола, их получение и содержащие их фармацевтические композиции
ATE225352T1 (de) Pyrrolo(2,1-b)(1,3)benzothiazepine mit atypisch antipsychotischer wirkung
MX9709451A (es) Derivados de benzisoxazol e indazol como agentes antipsicoticos.
DE60225155D1 (de) 3-substituierte 6,7-dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
ES2183862T3 (es) N-oxidos de 4-arilpiperacinas y 4-arilpiperidinas utilizados como medicamentos neurolepticos.
CA2281702A1 (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
NO950327L (no) Pyridoindolobenzodiazepiner og derivater som antipsykotiske midler
EA200001157A2 (ru) Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции
AU2914800A (en) (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for control of fertility
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
ECSP034778A (es) Derivados de 2-amino-propanol

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1100803

Country of ref document: EP

REN Ceased due to non-payment of the annual fee